Article Text

Download PDFPDF
115 Economic burden among migraine patients: United Kingdom perspective
  1. Paolo Martelletti1,
  2. Todd Schwedt2,
  3. Michel Lanteri-Minet3,
  4. Hans-Christoph Diener4,
  5. Elena Ruiz de la Torre5,
  6. Audrey Craven6,
  7. Simon Evans7,
  8. Donna Walsh8,
  9. Paula Dumas9,
  10. Annik Laflamme10
  1. 1European Headache Federation, Rome, Italy
  2. 2Department of Neurology, Mayo Clinic, Phoenix, AZ 85054, USA
  3. 3Département d’Evaluation et Traitement de la Douleur CHU Nice, Université Côte Azur, Nice, France
  4. 4Department of Neurology and Headache Center, University of Duisburg-Essen, Duisburg, Germany
  5. 5European Migraine and Headache Alliance (EMHA), Brussels, Belgium
  6. 6Migraine Association of Ireland (MAI), Dublin, Ireland
  7. 7Migraine Action, Leicester, UK
  8. 8European Federation of Neurological Associations, Brussels, Belgium
  9. 9Migraine Again, Irvine, USA
  10. 10Novartis Pharma AG, Basel, Switzerland


Objectives As part of the worldwide My Migraine Voice survey, this study evaluated the real-world healthcare resource utilization (HRU) and impact on work and activity impairment among people living with migraine in the United Kingdom (UK).

Methods An analysis was conducted using UK subset data from My Migraine Voice survey: a worldwide, cross-sectional, online study including respondents (≥18 years), with ≥4 monthly migraine days, with 90% having used preventive migraine treatment in the preceding three months. HRU (Emergency room [ER] visits and hospitalisations) and impact of migraine on work and daily activities were evaluated and compared amongst different preventive treatment failure (TF) patient subgroups.

Results Of the 690 respondents, 17% had visited ER (average 2.8 times/year), and 13% were hospitalised (average 3.0 days). Participants reported 13% missed working time (absenteeism), 52% reduction in productivity (presenteeism), and 58% reduction in both overall work productivity and daily activities due to migraine in last 7-days. HRU, absenteeism and presenteeism was higher in those with ≥2 TF vs patients with no TF.

Conclusion This study demonstrates the burden among patients with migraine in terms of HRU, work productivity loss, and activity impairment. The impact is increased in patients who have had ≥2 preventive treatment failures.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.